Free Trial
Tada emoji MarketBeat All Access — Now Just $5.00 for 5 Weeks

Eli Lilly and Company (LLY) Short Interest Ratio & Short Volume

Eli Lilly and Company logo
$705.31 +22.38 (+3.28%)
As of 02:54 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
Compare

Eli Lilly and Company Short Interest Data

Eli Lilly and Company (LLY) has a short interest of 7.17 million shares, representing 0.84% of the float (the number of shares available for trading by the public). This marks a -6.15% decrease in short interest from the previous month. The short interest ratio (days to cover) is 1.7, indicating that it would take 1.7 days of the average trading volume of 4.15 million shares to cover all short positions.

Current Short Interest
7,170,000 shares
Previous Short Interest
7,640,000 shares
Change Vs. Previous Month
-6.15%
Dollar Volume Sold Short
$5.30 billion
Short Interest Ratio
1.7 Days to Cover
Last Record Date
July 31, 2025
Outstanding Shares
946,460,000 shares
Float Size
848,740,000 shares
Short Percent of Float
0.84%
Today's Trading Volume
6,167,146 shares
Average Trading Volume
4,149,021 shares
Today's Volume Vs. Average
149%
Short Selling Eli Lilly and Company?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Eli Lilly and Company and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

LLY Short Interest Over Time

LLY Days to Cover Over Time

LLY Percentage of Float Shorted Over Time

Eli Lilly and Company Short Interest History

Export to Excel
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
7/31/20257,170,000 shares $5.30 billion -6.2%0.8%1.7 $739.62
7/15/20257,640,000 shares $5.90 billion -0.9%0.9%2 $772.74
6/30/20257,710,000 shares $6.01 billion -3.9%0.9%1.9 $779.35
6/15/20258,020,000 shares $6.56 billion -0.1%0.9%2 $818.56
5/31/20258,030,000 shares $5.93 billion +9.3%1.0%1.9 $738.33
5/15/20257,350,000 shares $5.38 billion No Change0.9%1.8 $732.40
4/30/20257,350,000 shares $6.61 billion +14.3%0.9%1.9 $899.78
4/15/20256,430,000 shares $4.86 billion -8.4%0.8%1.8 $756.55
3/31/20257,020,000 shares $5.79 billion +10.4%0.8%1.9 $825.42
3/15/20256,360,000 shares $5.17 billion -12.2%0.8%1.7 $813.55
2/28/20257,240,000 shares $6.66 billion +2.3%0.9%2 $920.44
2/15/20257,080,000 shares $5.98 billion +4.6%0.8%1.9 $844.82
1/31/20256,770,000 shares $5.49 billion -6.2%0.8%1.7 $811.61
1/15/20257,220,000 shares $5.39 billion +18.4%0.9%1.7 $746.42
12/31/20246,100,000 shares $4.71 billion +5.4%0.7%1.6 $772.00
12/15/20245,790,000 shares $4.57 billion -0.9%0.7%1.5 $789.12
11/30/20245,840,000 shares $4.64 billion -10.7%0.7%1.6 $795.35
11/15/20246,540,000 shares $4.88 billion -1.2%0.8%1.8 $745.89
10/31/20246,620,000 shares $5.49 billion +14.3%0.8%2.1 $829.84
10/15/20245,790,000 shares $5.29 billion No Change0.7%2 $913.85
9/30/20245,790,000 shares $5.13 billion -12.0%0.7%1.8 $885.56
9/15/20246,580,000 shares $6.08 billion +4.9%0.8%2 $923.71
8/31/20246,270,000 shares $6.02 billion -0.5%0.7%1.9 $960.02
8/15/20246,300,000 shares $5.87 billion +16.5%0.7%2 $931.58
7/31/20245,410,000 shares $4.35 billion -14.3%0.6%1.8 $804.27
7/15/20246,310,000 shares $6.00 billion +5.3%0.7%2.2 $950.46
6/30/20245,990,000 shares $5.42 billion -7.6%0.7%2.2 $905.38
6/15/20246,480,000 shares $5.69 billion +5.2%0.8%2.5 $878.45
5/31/20246,160,000 shares $5.06 billion +14.1%0.7%2.3 $821.11
5/15/20245,400,000 shares $4.25 billion +5.7%0.6%2 $787.24
4/30/20245,110,000 shares $3.99 billion -7.8%0.6%1.7 $781.56
4/15/20245,540,000 shares $4.16 billion +2.2%0.7%1.8 $751.20
3/31/20245,420,000 shares $4.22 billion -2.2%0.6%1.8 $777.96
3/15/20245,540,000 shares $4.18 billion +2.2%0.7%1.8 $755.36
2/29/20245,420,000 shares $4.08 billion +5.2%0.6%1.7 $753.61
2/15/20245,150,000 shares $3.90 billion +16.8%0.6%1.6 $757.09
1/31/20244,410,000 shares $2.84 billion -9.8%0.5%1.3 $645.10
1/15/20244,890,000 shares $3.14 billion -3.9%0.6%1.6 $642.92
12/31/20235,090,000 shares $2.97 billion -4.7%0.6%1.6 $582.92
12/15/20235,340,000 shares $3.05 billion -3.3%0.6%1.7 $571.46
3 Dirt-Cheap Stocks You Can’t Afford to Ignore (Ad)

Often, investors will overlook stocks just because they're cheap. It's a common thought that a cheap price tag means that something must be wrong with the company. But this couldn't be further from the case in many instances.

Get your FREE look at these THREE companies right here.
11/30/20235,520,000 shares $3.26 billion -5.5%0.7%1.7 $591.04
11/15/20235,840,000 shares $3.44 billion +6.8%0.7%1.8 $588.41
10/31/20235,470,000 shares $3.03 billion -14.4%0.7%1.8 $553.93
10/15/20236,390,000 shares $3.89 billion +13.1%0.8%2.1 $609.20
9/30/20235,650,000 shares $3.03 billion -9.9%0.7%1.9 $537.13
9/15/20236,270,000 shares $3.61 billion +11.6%0.7%2.2 $575.66
8/31/20235,620,000 shares $3.11 billion +8.3%0.7%2 $554.20
8/15/20235,190,000 shares $2.84 billion +8.6%0.6%1.8 $546.64
7/31/20234,780,000 shares $2.17 billion -7.0%0.6%1.7 $454.55
7/15/20235,140,000 shares $2.31 billion -1.9%0.6%1.7 $449.46
6/30/20235,240,000 shares $2.46 billion -7.8%0.6%1.8 $468.98
6/15/20235,680,000 shares $2.58 billion -5.3%0.7%1.9 $454.00
5/31/20236,000,000 shares $2.58 billion -1.6%0.7%1.9 $429.46
5/15/20236,100,000 shares $2.65 billion -1.6%0.7%1.9 $434.51
4/30/20236,200,000 shares $2.45 billion -18.1%0.7%1.9 $395.86
4/15/20237,570,000 shares $2.84 billion +4.7%0.9%2.4 $374.73
3/31/20237,230,000 shares $2.48 billion -11.0%0.9%2.2 $343.42
3/15/20238,120,000 shares $2.68 billion +19.2%1.0%2.7 $329.47
2/28/20236,810,000 shares $2.12 billion +30.5%0.8%2.4 $311.22
2/15/20235,220,000 shares $1.75 billion +5.9%0.6%1.9 $335.01
1/31/20234,930,000 shares $1.70 billion No Change0.6%1.7 $344.15
1/15/20234,930,000 shares $1.78 billion -12.3%0.6%1.7 $361.62
12/30/20225,620,000 shares $2.06 billion No Change0.6%2 $365.84
12/15/20225,620,000 shares $2.02 billion -15.0%0.6%1.8 $360.01
11/30/20226,610,000 shares $2.45 billion +17.8%0.8%2.2 $371.08
11/15/20225,610,000 shares $1.96 billion -8.0%0.7%1.9 $349.95
10/31/20226,100,000 shares $2.21 billion +12.6%0.7%2.1 $362.09
10/15/20225,420,000 shares $1.80 billion -5.7%0.6%1.9 $331.39
9/30/20225,750,000 shares $1.86 billion +7.9%0.7%2.1 $323.35
9/15/20225,330,000 shares $1.65 billion +2.9%0.6%2 $309.47
8/31/20225,180,000 shares $1.56 billion +7.5%0.7%2 $301.23
8/15/20224,820,000 shares $1.51 billion -2.8%0.6%1.7 $313.94
7/31/20224,960,000 shares $1.64 billion -9.2%0.6%1.7 $329.69
7/15/20225,460,000 shares $1.81 billion +10.8%0.7%1.9 $331.60
6/30/20224,930,000 shares $1.60 billion +14.9%0.6%1.7 $324.23
6/15/20224,290,000 shares $1.26 billion -16.2%0.5%1.4 $292.99
5/31/20225,120,000 shares $1.60 billion -2.1%0.7%1.7 $313.44
5/15/20225,230,000 shares $1.53 billion +4.0%0.7%1.8 $291.63
4/30/20225,030,000 shares $1.47 billion -19.1%0.6%1.7 $292.13
4/15/20226,220,000 shares $1.88 billion +7.4%0.8%2.2 $301.86
3/31/20225,790,000 shares $1.66 billion -12.1%0.7%1.9 $286.37
3/15/20226,590,000 shares $1.82 billion +1.4%0.8%2.3 $275.46
2/28/20226,500,000 shares $1.62 billion +21.3%0.8%2.2 $249.95
2/15/20225,360,000 shares $1.31 billion +13.3%0.7%1.7 $243.84
1/31/20224,730,000 shares $1.16 billion +8.0%0.6%1.6 $245.39
1/15/20224,380,000 shares $1.07 billion -8.6%0.6%1.4 $244.12
12/31/20214,790,000 shares $1.32 billion -22.6%0.6%1.6 $276.22
12/15/20216,190,000 shares $1.70 billion +4.0%0.8%2 $275.28
11/30/20215,950,000 shares $1.48 billion -16.7%0.8%2 $248.04
11/15/20217,140,000 shares $1.85 billion -19.2%0.9%2.7 $258.43
3 Dirt-Cheap Stocks You Can’t Afford to Ignore (Ad)

Often, investors will overlook stocks just because they're cheap. It's a common thought that a cheap price tag means that something must be wrong with the company. But this couldn't be further from the case in many instances.

Get your FREE look at these THREE companies right here.
10/29/20218,840,000 shares $2.25 billion +34.6%1.1%3.3 $254.76
10/15/20216,570,000 shares $1.56 billion +2.5%0.8%2.6 $237.88
9/30/20216,410,000 shares $1.48 billion +11.5%0.8%2.5 $231.05
9/15/20215,750,000 shares $1.34 billion -6.5%0.7%2.1 $233.73
8/31/20216,150,000 shares $1.59 billion No Change0.8%2.2 $258.29
8/13/20216,150,000 shares $1.62 billion -9.2%0.8%1.9 $264.21
7/30/20216,770,000 shares $1.65 billion -3.4%0.9%2.1 $243.50
7/15/20217,010,000 shares $1.62 billion +12.0%0.9%2.1 $231.47
6/30/20216,260,000 shares $1.44 billion -17.6%0.8%1.8 $229.52
6/15/20217,600,000 shares $1.70 billion +0.1%1.0%2.2 $223.52
5/28/20217,590,000 shares $1.52 billion -8.4%1.0%2.1 $199.74
5/14/20218,290,000 shares $1.62 billion -7.0%1.0%2.5 $194.94
4/30/20218,910,000 shares $1.62 billion +39.7%1.1%2.6 $182.20
4/15/20216,380,000 shares $1.17 billion -17.4%0.8%1.7 $183.00
3/31/20217,720,000 shares $1.43 billion +10.6%1.0%1.8 $185.50
3/15/20216,980,000 shares $1.45 billion +23.8%0.9%1.6 $208.08
2/26/20215,640,000 shares $1.15 billion -14.0%0.7%1.3 $203.82
2/12/20216,560,000 shares $1.33 billion -1.7%0.8%1.5 $202.58
1/29/20216,670,000 shares $1.40 billion +15.8%0.8%1.5 $210.12
1/15/20215,760,000 shares $1.08 billion +10.8%0.7%1.2 $186.69
12/31/20205,200,000 shares $868.45 million -24.5%0.7%1.2 $167.01
12/15/20206,890,000 shares $1.09 billion +24.1%0.9%1.7 $157.91
11/30/20205,550,000 shares $818.29 million +4.1%0.7%1.3 $147.44
11/15/20205,330,000 shares $758.89 million +9.0%0.7%1.3 $142.38
10/30/20204,890,000 shares $648.17 million -7.4%0.6%1.3 $132.55
10/15/20205,280,000 shares $783.87 million +40.1%0.7%1.6 $148.46
9/30/20203,770,000 shares $558.04 million -39.9%0.5%1.2 $148.02
9/15/20206,270,000 shares $941.00 million +34.6%0.8%2 $150.08
8/31/20204,660,000 shares $691.50 million +9.7%0.6%1.5 $148.39

LLY Short Interest - Frequently Asked Questions

What is Eli Lilly and Company's current short interest?

Short interest is the volume of Eli Lilly and Company shares that have been sold short but have not yet been closed out or covered. As of July 31st, traders have sold 7,170,000 shares of LLY short. 0.84% of Eli Lilly and Company's shares are currently sold short. Learn More on Eli Lilly and Company's current short interest.

What is a good short interest ratio for Eli Lilly and Company?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. LLY shares currently have a short interest ratio of 2.0. Learn More on Eli Lilly and Company's short interest ratio.

Which institutional investors are shorting Eli Lilly and Company?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Eli Lilly and Company: LMR Partners LLP, Hudson Bay Capital Management LP, Group One Trading LLC, Cubist Systematic Strategies LLC, BNP Paribas Financial Markets, Balyasny Asset Management L.P., Bank of America Corp DE, 683 Capital Management LLC, Jane Street Group LLC, Quantinno Capital Management LP, HUB Investment Partners LLC, Volterra Technologies LP, Squarepoint Ops LLC, Alphadyne Asset Management LP, Diadema Partners LP, Qube Research & Technologies Ltd, B Group Inc., Maven Securities LTD, Capula Management Ltd, Marshall Wace LLP, Walleye Capital LLC, Walleye Trading LLC, Lido Advisors LLC, Capital Fund Management S.A., Hsbc Holdings PLC, Eisler Capital Management Ltd., MAI Capital Management, JPMorgan Chase & Co., Greenland Capital Management LP, Citigroup Inc., Persistent Asset Partners Ltd, Tortoise Investment Management LLC, Simplex Trading LLC, Bank of New York Mellon Corp, Mission Wealth Management LP, Wolverine Asset Management LLC, Allianz Asset Management GmbH, Twin Tree Management LP, Johnson Investment Counsel Inc., Brandywine Oak Private Wealth LLC, US Bancorp DE, Valeo Financial Advisors LLC, IMC Chicago LLC, Halbert Hargrove Global Advisors LLC, Novem Group, Fortitude Family Office LLC, Dynamic Advisor Solutions LLC, Modern Wealth Management LLC, and Quaker Wealth Management LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Eli Lilly and Company?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.84% of Eli Lilly and Company's floating shares are currently sold short.

Is Eli Lilly and Company's short interest increasing or decreasing?

Eli Lilly and Company saw a decline in short interest during the month of July. As of July 31st, there was short interest totaling 7,170,000 shares, a decline of 6.2% from the previous total of 7,640,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Eli Lilly and Company's float size?

Eli Lilly and Company currently has issued a total of 946,460,000 shares. Some of Eli Lilly and Company's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Eli Lilly and Company currently has a public float of 848,740,000 shares.

How does Eli Lilly and Company's short interest compare to its competitors?

0.84% of Eli Lilly and Company's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Eli Lilly and Company: Amgen Inc. (2.33%), Biogen Inc. (2.71%), Incyte Corporation (3.85%), Moderna, Inc. (18.29%), Viking Therapeutics, Inc. (26.61%), Vertex Pharmaceuticals Incorporated (1.71%), AbbVie Inc. (0.86%), Johnson & Johnson (0.71%), Merck & Co., Inc. (1.04%), Pfizer Inc. (1.90%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($70.87 billion), Invesco QQQ ($30.12 billion), iShares Russell 2000 ETF ($19.85 billion), iShares 20+ Year Treasury Bond ETF ($10.34 billion), MicroStrategy Incorporated ($8.98 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($7.61 billion), SPDR S&P Biotech ETF ($6.81 billion), Invesco S&P 500 Equal Weight ETF ($6.14 billion), Palo Alto Networks, Inc. ($5.97 billion), and Super Micro Computer, Inc. ($5.28 billion). View all of the most shorted stocks.

What does it mean to sell short Eli Lilly and Company stock?

Short selling LLY is an investing strategy that aims to generate trading profit from Eli Lilly and Company as its price is falling. LLY shares are trading up $15.59 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Eli Lilly and Company?

A short squeeze for Eli Lilly and Company occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of LLY, which in turn drives the price of the stock up even further.

How often is Eli Lilly and Company's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LLY, twice per month. The most recent reporting period available is July, 31 2025.



Related Companies
Short Interest Tools

This page (NYSE:LLY) was last updated on 8/15/2025 by MarketBeat.com Staff
From Our Partners
Trump’s national nightmare is here
Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...
Porter & Company | Sponsored
Alex’s “Next Magnificent Seven” stocks
The original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...
The Oxford Club | Sponsored
The Robotics Revolution has arrived … and one $7 stock could take off as a result.
Something big is brewing in Washington. According to my research, an executive order from President Trump c...
Weiss Ratings | Sponsored
Altucher: It Looks Like My Trump prediction is coming true
New Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...
Paradigm Press | Sponsored
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsored
GENIUS Act: Cancel Your Money?
A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...
Priority Gold | Sponsored
Elon’s Secret Social Security Bombshell
To All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...
Banyan Hill Publishing | Sponsored
Trump set to Boost Social Security Checks by 400%?
If you're collecting or planning to collect social security... You should see this presentation about Presi...
InvestorPlace | Sponsored